BIOLINE REAGENTS LIMITED
Get an alert when BIOLINE REAGENTS LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-04-25 (in 11mo)
Last made up 2026-04-11
Watchouts
None on the register
Cash
£3M
lowest in 5 filed years
Net assets
£8M
Equity attributable
Employees
36
lowest in 5 filed years
Profit before tax
£9M
lowest in 5 filed years
Net assets
7-year trend · vs Basic Materials median
Accounts
7-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-09-30 | 2021-09-30 | 2021-10-01 | 2022-09-30 | 2022-10-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Turnover | £53,663,449 | £78,381,531 | — | £63,732,319 | — | £21,102,581 | £17,077,400 | |
| Operating profit | £37,934,569 | £55,792,891 | — | £48,553,957 | — | £9,715,163 | £9,458,971 | |
| Profit before tax | £37,930,063 | £55,762,155 | — | £48,516,193 | — | £9,689,418 | £9,436,137 | |
| Net profit | — | — | — | £39,181,310 | — | £7,537,400 | £6,990,005 | |
| Cash | £9,789,902 | £5,583,787 | — | £13,344,974 | — | £3,577,928 | £2,818,907 | |
| Total assets less current liabilities | £18,252,508 | £19,569,058 | — | £20,331,153 | — | £6,833,809 | £7,808,689 | |
| Net assets | £18,252,508 | £19,569,058 | — | £20,250,368 | — | £6,787,768 | £7,777,773 | |
| Equity | £18,252,508 | £19,569,058 | £19,569,058 | £20,250,368 | £20,250,368 | £6,787,768 | £7,777,773 | |
| Average employees | 44 | 42 | — | 43 | — | 42 | 36 | |
| Wages | — | — | — | £2,487,264 | — | £2,894,342 | £2,496,327 | |
| Directors' remuneration | — | — | — | — | — | £0 | £0 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-09-30 | 2021-09-30 | 2021-10-01 | 2022-09-30 | 2022-10-01 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating margin | 70.7% | 71.2% | — | 76.2% | — | 46.0% | 55.4% | |
| Net margin | — | — | — | 61.5% | — | 35.7% | 40.9% | |
| Return on capital employed | 207.8% | 285.1% | — | 238.8% | — | 142.2% | 121.1% | |
| Current ratio | — | — | — | — | — | 3.32x | 5.02x | |
| Interest cover | 5392.26x | 1815.23x | — | 1285.72x | — | 377.36x | 414.25x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- BIOLINE REAGENTS LIMITED 2010-02-08 → present
- QUANTACE LIMITED 2003-07-19 → 2010-02-08
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Hurst Accountants Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “There have been no significant events affecting the Company since the year end.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| KITZMILLER, Andrew Scott | Director | 2022-03-23 | Mar 1979 | American |
| MOSER, Emerson | Director | 2023-07-01 | Jun 1976 | American |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CALZAVARA, Victor | Secretary | 2008-09-03 | 2012-09-14 |
| PARKER, Alan | Secretary | 2012-09-14 | 2022-03-23 |
| TAYLOR, Simon | Secretary | 2003-07-19 | 2008-11-01 |
| CHETTLEBURGH'S SECRETARIAL LTD | Corporate Secretary | 2005-11-11 | 2007-01-17 |
| CHETTLEBURGHS SECRETARIAL LTD | Corporate Nominee Secretary | 2003-07-19 | 2003-07-19 |
| BALDASARE, Bryan | Director | 2019-06-25 | 2021-12-31 |
| CALZAVARA, Marco Joseph | Director | 2008-03-31 | 2018-06-12 |
| EBERLY, Richard Lee | Director | 2012-09-14 | 2018-02-20 |
| HIRANI, Kasturben | Director | 2009-09-01 | 2016-01-29 |
| KENNY, John Patrick | Director | 2018-01-23 | 2023-06-30 |
| KRAEUTLER, John Andrew | Director | 2012-09-14 | 2018-01-23 |
| LEGRAND, Eugene Lewis | Director | 2008-09-03 | 2009-04-05 |
| LEGRAND, Eugene Lewis | Director | 2003-07-19 | 2008-03-31 |
| LUEKE, Melissa Ann | Director | 2017-01-26 | 2018-12-13 |
| OTTENHOF, Harald Henri | Director | 2018-06-12 | 2020-08-28 |
| PARKER, Alan Michael | Director | 2009-09-01 | 2022-03-23 |
| RASMUSSEN, Eric Scott | Director | 2019-01-25 | 2019-06-21 |
| SMITH, Julie Diana, Ms. | Director | 2022-03-23 | 2023-01-31 |
| WELTZIEN, De Lourdes Guerra | Director | 2020-08-28 | 2025-08-08 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Meridian Bioscience International Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 102 total filings
Material constitutional events — rename, articles re-file, resolution
- 2023-05-13 MA Memorandum articles
- 2023-02-10 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-04-30 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2025-09-15 | AA | accounts | Accounts with accounts type full | |
| 2025-09-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-05-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-30 | AA | accounts | Accounts with accounts type full | |
| 2024-04-12 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-25 | AA | accounts | Accounts with accounts type full | |
| 2023-07-03 | TM01 | officers | Termination director company with name termination date | |
| 2023-07-03 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-13 | MA | incorporation | Memorandum articles | |
| 2023-04-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-04-11 | AA01 | accounts | Change account reference date company current extended | |
| 2023-02-10 | RESOLUTIONS | resolution | Resolution | |
| 2023-02-03 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-02-03 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-02-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-02-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-01-31 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-07 | AAMD | accounts | Accounts amended with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.